Search results for “Addison Disease” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 152 patents, we discovered top 45 key players by total patent application. Amgen, Inc., OncoNOx ApS, Pola Chemical Industries, Inc. are dominant in this area. They take 31.58% of the total patent filing.
Amgen, Inc.
California, United States
Patent: 28
OncoNOx ApS
Hovedstaden, Denmark
Patent: 10
Pola Chemical Industries, Inc.
Kanagawa-ken, Japan
Patent: 10
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 9
Iverson Genetic Diagnostics, Inc.
South Carolina, United States
Patent: 8
OncoImmune, Inc.
United States
Patent: 6
Repos Pharma AB
Sweden
Patent: 6
Research Development Foundation
United States
Patent: 4
Sumitomo Pharmaceuticals Co., Ltd.
Osaka-fu, Japan
Patent: 4
Apodemus AB
STOCKHOLM, Sweden
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 34 patents applied in the last 5 years. We discover 12 most active companies in this area. The fast-growing OncoImmune, Inc., Children's National Hospital (District of Columbia), Repos Pharma AB take 52.94% of patent filing during this period.
OncoImmune, Inc.
United States
Patent: 6
Children's National Hospital (District of Columbia)
District of Columbia, United States
Patent: 6
Repos Pharma AB
Sweden
Patent: 6
Purdue Research Foundation
Indiana, United States
Patent: 4
Insignis Therapeutics, Inc.
undefined undefined
Patent: 3
Nogra Pharma Ltd.
DUBLIN, Ireland
Patent: 2
Société des Produits Nestlé SA
Vaud, Switzerland
Patent: 2
Guangzhou Nanfeng Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 1
Dicerna Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
I-MAB Biopharma Co., Ltd.
Shanghai Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 34 patents in last 5 years, we discover 12 new entrants. OncoImmune, Inc., Children's National Hospital (District of Columbia), Repos Pharma AB are the most active new entrants in this area.
OncoImmune, Inc.
United States
Patent: 6
Children's National Hospital (District of Columbia)
District of Columbia, United States
Patent: 6
Repos Pharma AB
Sweden
Patent: 6
Purdue Research Foundation
Indiana, United States
Patent: 4
Insignis Therapeutics, Inc.
undefined undefined
Patent: 3
Nogra Pharma Ltd.
DUBLIN, Ireland
Patent: 2
Société des Produits Nestlé SA
Vaud, Switzerland
Patent: 2
Guangzhou Nanfeng Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 1
Dicerna Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
I-MAB Biopharma Co., Ltd.
Shanghai Shi, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 20 patents, we discovered top 5 universities and scientific research institutions by total patent application. The Johns Hopkins University, New York University, Regents of the University of Colorado are dominant in this area. They take 45.00% of the total patent filing.
The Johns Hopkins University
United States
Patent: 4
New York University
New York, United States
Patent: 3
Regents of the University of Colorado
Colorado, United States
Patent: 2
Shanghai Second Medical University
China
Patent: 2
Queen Mary University of London
United Kingdom
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: